In a blow to British drugmaker Indivior on Tuesday, Supreme Court Chief Justice John Roberts opened the door for copycat versions of its opioid-addiction treatment, Suboxone Film. The ruling is a victory for Dr. Reddy’s Laboratories, which had been blocked from selling its generic version. (Reuters)
Get to know MM&M’s new top editor. Steve Madden, who was recently appointed editor-in-chief of flagship Haymarket Business Media brand MM&M, is a guest on this week’s edition of The MM&M Podcast, on which he discusses his experience and editorial philosophy. (MM&M)
The FDA is discouraging people from getting “young blood transfusions.” The practice, which hasn’t been proven to have medical benefits, requires people to be infused with younger people’s blood plasma. Companies charge thousands of dollars for the procedure. (CNBC)
The Philippines has stopped the marketing, sale, and distribution of a dengue vaccine from Sanofi, saying the French drugmaker did not meet the orders of its regulators. The leader of the country’s Food and Drug Administration cited Sanofi’s “brazen defiance” of its guidelines. (Reuters)
Intercept Pharmaceuticals said its treatment for the fatty liver disease NASH had hit its primary goal in a phase 3 trial. A week earlier, Gilead Sciences said a trial for a competing drug had failed. There are no approved treatments for the liver disease known as NASH, or nonalcoholic steatohepatitis. (MarketWatch)
